Status:
RECRUITING
Global Hip Dysplasia Registry
Lead Sponsor:
University of British Columbia
Conditions:
Hip Dislocation, Congenital
Hip Dysplasia, Congenital, Nonsyndromic
Eligibility:
All Genders
1-10 years
Brief Summary
Developmental dysplasia of the hip (DDH) is the most common hip condition affecting infants and children. DDH represents a spectrum of issues affecting the hip joint - a "ball-and-socket" joint. When ...
Detailed Description
DDH is the most common pediatric hip condition, with 1-3% of all newborns diagnosed at birth. However, the true incidence of DDH is difficult to quantify due to significant variations in diagnostic cr...
Eligibility Criteria
Inclusion
- Between the ages of 0 and 10 years at time of initial diagnosis
- Referred for DDH screening due to specific risk factors OR diagnosed with DDH
- Diagnosis confirmed with appropriate ultrasonographic or radiographic imaging
Exclusion
- Known or suspected neuromuscular, collagen, chromosomal or lower extremity congenital anomalies
- Teratologic hip dislocation (syndromic-associated dislocations)
- Over 10 years of age at initial diagnosis
- Received prior treatment for DDH without appropriate imaging or documentation
Key Trial Info
Start Date :
September 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2028
Estimated Enrollment :
5000 Patients enrolled
Trial Details
Trial ID
NCT04117685
Start Date
September 1 2016
End Date
December 31 2028
Last Update
November 18 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
British Columbia Children's Hospital
Vancouver, British Columbia, Canada, V6H 3N1